IXHL
insider transactionsIncannex Healthcare Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
1.7M sh
Own +1687%
-
Grant·A
Director
$0
1.7M sh
Own +623%
-
Grant·A
Latham Joel KEY
CEO and President
$0
22.6M sh
Own +1433%
-
Grant·A
Director
$0
1.7M sh
Own +219%
-
Grant·A
Director
$0
11.3M sh
Own +1616%
-
Grant·A
Swan Joseph KEY
CFO, Treasurer and Secretary
$0
869.6K sh
Own +1679%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 14, 2025 | Clark Robert | Grant A | 1.7M | $0 |
| Nov 14, 2025 | Widdows Peter | Grant A | 1.7M | $0 |
| Nov 14, 2025 | Latham Joel KEY | Grant A | 22.6M | $0 |
| Nov 14, 2025 | Anastassov George | Grant A | 1.7M | $0 |
| Nov 14, 2025 | Valentine Troy | Grant A | 11.3M | $0 |
| Nov 14, 2025 | Swan Joseph KEY | Grant A | 869.6K | $0 |
About IXHL insider trading
This page tracks insider transactions for Incannex Healthcare Inc. (IXHL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.